150. HIV: Treatment: Friday, 12:15 - 1:30 p.m.
Poster Session: HIV: Treatment
Mehri McKellar, MD (she/her/hers)
Associate Professor of Medicine
Duke University Hospital
DURHAM, North Carolina, United States
Paula Teichner, PharmD
Medical Director
ViiV Healthcare
Chicago, Illinois, United States
Christopher Bettacchi, MD
Infectious Diseases Physician
North Texas Infectious Disease Consultants
Dallas, Texas, United States
Jonathan Angel, MD
Ottawa Hospital Research Institute
Ottawa, Ontario, Canada
Lori A. Gordon, PharmD
ViiV Healthcare
Miami, Florida, United States
Kenneth Sutton, MA
Clinical Development Manager
ViiV Healthcare
Research Triangle Park, North Carolina, United States
Denise Sutherland-Phillips, MD
Medical Monitor/MD
ViiV Healthcare
Durham, North Carolina, United States
Christine L. Talarico, M.S.
Clinical Virologist
ViiV Healthcare
Research Triangle Park, North Carolina, United States
Rimgaile Urbaityte, MSc
Manager, Statistics
GSK
Uxbridge, England, United Kingdom
Rodica Van Solingen-Ristea, MD
Clinical Leader
Janssen Research & Development, LLC
Beerse, Antwerpen, Belgium
Bryan Baugh, MD
Global Affairs Leader, Infectious Diseases and Vaccines
Janssen Research & Development LLC
Raritan, New Jersey, United States
.jpg "Ronald D'Amico, DO, MSc photo")
Ronald D'Amico, DO, MSc
Medical Director
ViiV Healthcare
Research Triangle Park, North Carolina, United States
Jean A. van Wyk, MBChB, MFPM
Medical Director
ViiV Healthcare, Brentford, UK
Brentford, England, United Kingdom